MCANet: shared-weight-based MultiheadCrossAttention network for drug-target interaction prediction
暂无分享,去创建一个
[1] Yaohang Li,et al. IIFDTI: predicting drug-target interactions through interactive and independent features based on attention mechanism , 2022, Bioinform..
[2] Mingxing Tan,et al. PolyLoss: A Polynomial Expansion Perspective of Classification Loss Functions , 2022, ICLR.
[3] Guohua Wang,et al. Supervised graph co-contrastive learning for drug-target interaction prediction , 2022, Bioinform..
[4] Hojung Nam,et al. Sequence-based prediction of protein binding regions and drug–target interactions , 2022, Journal of Cheminformatics.
[5] Zhenhua Feng,et al. CPInformer for Efficient and Robust Compound-Protein Interaction Prediction , 2022, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[6] Yaohang Li,et al. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction , 2022, Bioinform..
[7] Qichang Zhao,et al. HyperAttentionDTI: improving drug-protein interaction prediction by sequence-based deep learning with attention mechanism , 2021, Bioinform..
[8] Guohua Wang,et al. Drug-target interaction predication via multi-channel graph neural networks , 2021, Briefings Bioinform..
[9] Zhiqiang Wei,et al. MCN-CPI: Multiscale Convolutional Network for Compound–Protein Interaction Prediction , 2021, Biomolecules.
[10] Congmin Jia,et al. Quantitative prediction model for affinity of drug–target interactions based on molecular vibrations and overall system of ligand-receptor , 2021, BMC Bioinformatics.
[11] Guohua Wang,et al. Evaluating disease similarity based on gene network reconstruction and representation , 2021, Bioinform..
[12] Khushnood Abbas,et al. A survey on deep learning and its applications , 2021, Comput. Sci. Rev..
[13] Jie Zhang,et al. BridgeDPI: A Novel Graph Neural Network for Predicting Drug-Protein Interactions , 2021, ArXiv.
[14] Parvin Razzaghi,et al. DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks , 2020, Bioinform..
[15] Arne Elofsson,et al. TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments , 2020, Bioinform..
[16] Jiajie Peng,et al. Identifying drug-target interactions based on graph convolutional network and deep neural network , 2020, Briefings Bioinform..
[17] Jimeng Sun,et al. MolTrans: Molecular Interaction Transformer for drug–target interaction prediction , 2020, Bioinform..
[18] Natalia Gimelshein,et al. PyTorch: An Imperative Style, High-Performance Deep Learning Library , 2019, NeurIPS.
[19] Ming Du,et al. Computer vision algorithms and hardware implementations: A survey , 2019, Integr..
[20] Hojung Nam,et al. DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences , 2018, PLoS Comput. Biol..
[21] Jugal K. Kalita,et al. A Survey of the Usages of Deep Learning for Natural Language Processing , 2018, IEEE Transactions on Neural Networks and Learning Systems.
[22] Asif Ali Laghari,et al. Machine Learning in Computer Vision: A Review , 2018, EAI Endorsed Trans. Scalable Inf. Syst..
[23] Jun Sese,et al. Compound‐protein interaction prediction with end‐to‐end learning of neural networks for graphs and sequences , 2018, Bioinform..
[24] Yong Zhou,et al. Prediction of Drug–Target Interaction Networks from the Integration of Protein Sequences and Drug Chemical Structures , 2017, Molecules.
[25] Shuigeng Zhou,et al. Boosting compound-protein interaction prediction by deep learning , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[26] Yang Zhang,et al. GLASS: a comprehensive database for experimentally validated GPCR-ligand associations , 2015, Bioinform..
[27] Tao Xu,et al. Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis , 2014, J. Chem. Inf. Model..
[28] Alexander Golbraikh,et al. Application of Quantitative Structure–Activity Relationship Models of 5-HT1A Receptor Binding to Virtual Screening Identifies Novel and Potent 5-HT1A Ligands , 2014, J. Chem. Inf. Model..
[29] Mindy I. Davis,et al. Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.
[30] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[31] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[32] Van V. Brantner,et al. Estimating the cost of new drug development: is it really 802 million dollars? , 2006, Health affairs.
[33] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[34] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[35] Andrew L. Maas. Rectifier Nonlinearities Improve Neural Network Acoustic Models , 2013 .
[36] Antje Chang,et al. BRENDA , the enzyme database : updates and major new developments , 2003 .
[37] Yoshua Bengio,et al. Gradient-based learning applied to document recognition , 1998, Proc. IEEE.
[38] BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm580 Systems biology , 2022 .